UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: September 30, 2024
For the quarterly period ended: March 31, 2025
or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from: _____________ to _____________

———————

FARMHOUSE, INC.

(Exact name of registrant as specified in its charter)

———————

NEVADA (NV)	333-238326	46-3321759
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

548 Market Street, Suite 90355, San Francisco, CA 94104

(Address of Principal Executive Office) (Zip Code)

(888) 420-6856

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

———————

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

[X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

[X] Yes [ ] No

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer [ ]		Accelerated filer [ ]
	Non-accelerated filer [ ]		Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act),

☐ Yes [X] No

The number of shares of the issuer’s Common Stock outstanding as of ~~April~~July 2422, 2025 is 17,925,950.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q for the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025 (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” and similar expressions identify forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Report. Although we believe our expectations are reasonable, we cannot guarantee future results. Except as required by law, we undertake no obligation to update any forward-looking statements.

CERTAIN TERMS USED IN THIS REPORT

Unless otherwise indicated, references to “we,” “us,” “our,” the “Registrant,” the “Company,” or “Farmhouse” refer to Farmhouse, Inc. ~~WeedClub®, Friends in High Places®, WeedClub Select®, and @420® are registered trademarks of the Company used throughout this Report.~~

FARMHOUSE, INC. AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

~~September~~March 3031, ~~2024~~2025

INDEX

PART I – FINANCIAL INFORMATION3

PART I – FINANCIAL INFORMATION		3

Item 1.	Interim condensed consolidated financial statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition
	and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	22
Item 4.	Controls and Procedures	22

PART II – OTHER INFORMATION		22

Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	23

SIGNATURE		24

CERTIFICATIONS

Item 1.Interim condensed consolidated financial statements3

Item 2.Management’s Discussion and Analysis of Financial Condition

and Results of Operations20

Item 3.Quantitative and Qualitative Disclosures about Market Risk32

Item 4.Controls and Procedures32

PART II – OTHER INFORMATION33

Item 1.Legal Proceedings33

Item 1A.Risk Factors34

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds34

Item 3.Defaults Upon Senior Securities36

Item 4.Mine Safety Disclosures36

Item 5.Other Information36

Item 6.Exhibits36

SIGNATURE37

CERTIFICATIONS38

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED BALANCE SHEETS
	September 30,		December 31,
	March 31,		December 31,
	2024		2023
	2025		2024
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	-
Cash	$	19,317	$	413
Accounts receivable		-		4,170
Prepaid expenses		7,500		4,200
Prepaid expenses		8,400		3,990
Total current assets		26,817		4,613
Total current assets		8,400		8,160
Deposit on Investment		26,175		26,175
Deposit on Investment		26,175		-
Total assets	$	52,992	$	30,788
Total assets	$	34,575	$	8,160
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	5347,~~375~~223	$	4559,~~435~~701
Accrued legal fees		~~416~~10,~~042~~070		~~387~~425,~~501~~625
Accrued payroll and payroll taxes		1,~~267~~359,~~860~~932		1,~~129~~313,~~752~~896
Accrued liabilities		~~243~~11,~~926~~510		~~204~~37,~~050~~946
Accrued interest payable		7482,~~010~~815		6179,~~745~~226
Convertible notes payable, in default		45,000		45,000
Notes payable, $50,000 in default		85,567		50,000
Notes payable, in default		68,400		85,567
Notes payable to related party		4,500		-
Due to related parties, $4,500 in default		316,079		292,397
Accrued interest payable to related party		121		-
Total current liabilities		1,941,029		2,339,358
Due to related parties		57,978		28,958
Total current liabilities		2,248,379		1,952,441
Long-term liabilities:
Convertible notes payable, long-term		34383,~~000~~100		34,000
Total long-term liabilities		34383,~~000~~100		34,000
Total liabilities		2,~~282~~324,~~379~~129		12,~~986~~373,~~441~~358
Commitments and contingencies		-		-
Stockholders’ deficit:
Preferred stock; $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding at September 30, 2024 and December 31, 2023		-		-
Preferred stock; $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024		-		-
Common stock; $0.0001 par value, 295,000,000 shares authorized, 17,925,950 and 17,325,950 shares issued and outstanding at September 30, 2024 and December 31, 2023		1,793		1,733
Common stock; $0.0001 par value, 295,000,000 shares authorized, 17,925,950 shares issued and outstanding as of March 31, 2025 and December 31, 2024		1,793		1,793
Additional paid-in capital		4,~~418~~428,~~274~~613		4,~~325~~425,~~474~~468
Accumulated deficit		(6,~~667~~701,~~871~~543)		(6,~~305~~769,~~488~~831)
Total stockholders’ deficit		(2,~~247~~271,~~804~~137)		(12,~~978~~342,~~281~~570)
Total liabilities and stockholders’ deficit	$	3452,~~575~~992	$	830,~~160~~788
The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
	For the three months ended Sept. 30,				For the nine months ended Sept. 30,
	2024		2023		2024		2023
REVENUES
Revenues	$	-	$	5,503	$	4,154	$	10,707
Costs of revenues		-		(2,404)		(1,874)		(5,006)
Gross margin		-		3,099		2,280		5,701
OPERATING EXPENSES
General and administrative		67,604		81,717		219,474		251,064
Professional fees		25,220		24,708		104,262		157,383
Total operating expenses		92,824		106,425		323,736		408,447
LOSS FROM OPERATIONS		(92,824)		(103,326)		(321,456)		(402,746)
OTHER INCOME (EXPENSE):
Interest expense		(14,369)		(13,032)		(40,927)		(38,004)
Total other income (expense)		(14,369)		(13,032)		(40,927)		(38,004)
NET LOSS	$	(107,193)	$	(116,358)	$	(362,383)	$	(440,750)
BASIC AND DILUTED NET LOSS PER SHARE	$	(0.01)	$	(0.01)	$	(0.02)	$	(0.03)
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		17,902,254		17,075,950		17,517,847		17,075,950
The accompanying notes are an integral part of these condensed consolidated financial statements

CONSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
FARMHOUSE, INC. AND SUBSIDIARY
For the three and nine months ended September 30, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
	Common Stock							Accumulated
	For the three months ended March 31,
	Shares		Par Value			Paid-in Capital		Deficit		Total
	2025			2024
Balance at December 31, 2023	17,325,950		$	1,733		$	4,325,474	$	(6,305,488)	$	(1,978,281)
REVENUES
Stock-based compensation on RSA's vested	-			-			15,875		-		15,875
Revenues	$	-		$	2,261
Net loss	-			-			-		(116,071)		(116,071)
Costs of revenues		-			(1,131)
Balance at March 31, 2024	17,325,950			1,733			4,341,349		(6,421,559)		(2,078,477)
Gross margin		-			1,130
Common stock sold	62,500			6			24,994		-		25,000
OPERATING EXPENSES
Common stock issued for Restricted Stock Awards	340,000			34			(34)		-		-
General and administrative		67,110			74,180
Stock-based compensation on RSA's vested	-			-			19,915		-		19,915
Professional fees		23,684			29,923
Net loss	-			-			-		(139,119)		(139,119)
Total operating expenses		90,794			104,103
Balance at June 30, 2024	17,728,450			1,773			4,386,224		(6,560,678)		(2,172,681)
LOSS FROM OPERATIONS		(90,794)			(102,973)
Common stock issued for Restricted Stock Awards	10,000			1			(1)		-		-
OTHER INCOME (EXPENSE):
Deposit on Investment	187,500			19			26,156		-		26,175
Gain on extinguishment of debt		174,935			-
Stock-based compensation on RSA's vested	-			-			5,895		-		5,895
Interest expense		(15,853)			(13,098)
Net loss	-			-			-		(107,193)		(107,193)
Total other income (expense)		159,082			(13,098)
Balance at September 30, 2024	17,925,950		$	1,793		$	4,418,274	$	(6,667,871)	$	(2,247,804)
NET INCOME (LOSS)	$	68,288		$	(116,071)
The accompanying notes are an integral part of these condensed consolidated financial statements
BASIC AND DILUTED NET INCOME (LOSS) PER SHARE	$	0.00		$	(0.01)
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		17,925,950			17,325,950
The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and nine months ended September 30, 2023
(unaudited)
	Common Stock					Accumulated
	Shares	Par Value		Paid-in Capital		Deficit		Total
Balance at December 31, 2022	17,075,950	$	1,708	$	4,159,075	$	(5,744,699)	$	(1,583,916)
Stock-based compensation on RSA's vested	-		-		58,259		-		58,259
Net loss	-		-		-		(171,315)		(171,315)
Balance at March 31, 2023	17,075,950		1,708		4,217,334		(5,916,014)		(1,696,972)
Stock-based compensation on RSA's vested	-		-		58,259		-		58,259
Net loss	-		-		-		(153,077)		(153,077)
Balance at June 30, 2023	17,075,950		1,708		4,275,593		(6,069,091)		(1,791,790)
Stock-based compensation on RSA's vested	-		-		19,934				19,934
Net loss	-		-		-		(116,358)		(116,358)
Balance at September 30, 2023	17,075,950	$	1,708	$	4,295,527	$	(6,185,449)	$	(1,888,214)
The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
CONSENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the three months ended March 31, 2025
For the nine months ended September 30,
(unaudited)
(unaudited)
	Common Stock							Accumulated
	2024			2023
	Shares		Par Value			Paid-in Capital		Deficit		Total
CASH FLOWS FROM OPERATING ACTIVITIES:
Balance at December 31, 2024	17,925,950		$	1,793		$	4,425,468	$	(6,769,831)	$	(2,342,570)
Net loss	$	(362,383)		$	(440,750)
Stock-based compensation on RSA's vested	-			-			3,145		-		3,145
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Net income	-			-			-		68,288		68,288
Stock-based compensation on RSA's vested		41,685			136,452
Balance at March 31, 2025	17,925,950		$	1,793		$	4,428,613	$	(6,701,543)	$	(2,271,137)
Changes in operating assets and liabilities:
The accompanying notes are an integral part of these condensed consolidated financial statements
Accounts receivable		4,170			(2,320)
Prepaid expenses		(4,410)			(190)
Accounts payable		6,773			21,363
Accrued legal fees		28,541			29,781
Accrued payroll and payroll taxes		138,108			138,108
Accrued liabilities		39,876			36,000
Accrued interest payable		12,265			9,158
Accrued interest payable to related party		121			-
Net cash used in operating activities		(95,254)			(72,398)
CASH FLOWS FROM INVESTING ACTIVITIES:		-			-
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock		25,000			-
Proceeds from borrowings on note payable		35,567			-
Proceeds from borrowings on note payable from related party		4,500			-
Proceeds from borrowings of convertible notes payable		-			34,000
Borrowings from related party debt and short-term advances		30,187			2,751
Repayment of related party debt and short-term advances		-			(21,255)
Net cash provided by financing activities		95,254			15,496
NET CHANGE IN CASH		-			(56,902)
CASH AT BEGINNING OF PERIOD		-			62,063
CASH AT END OF PERIOD	$	-		$	5,161
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	$	-		$	-
Income taxes	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Repayment of related party advances with credit card	$	1,167		$	2,490
Deposit in investment	$	26,175		$	-
The accompanying notes are an integral part of these condensed consolidated financial statements

CONSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three months ended March 31, 2024
(unaudited)

	Common Stock					Accumulated
	Shares	Par Value		Paid-in Capital		Deficit		Total

Balance at December 31, 2023	17,325,950	$	1,733	$	4,325,474	$	(6,305,488)	$	(1,978,281)

Stock-based compensation on RSA's vested	-		-		15,875		-		15,875
Net loss	-		-		-		(116,071)		(116,071)
Balance at March 31, 2024	17,325,950	$	1,733	$	4,341,349	$	(6,421,559)	$	(2,078,477)


The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the three months ended March 31,
(unaudited)

	2025		2024

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	68,288	$	(116,071)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Gain on extinguishment of debt		(174,935)		-
Stock-based compensation on RSA's vested		3,145		15,875
Changes in operating assets and liabilities:
Accounts receivable		-		3,311
Prepaid expenses		(3,300)		3,828
Accounts payable		(4,208)		14,526
Accrued legal fees		9,375		9,479
Accrued payroll and payroll taxes		46,036		46,036
Accrued liabilities		(436)		-
Accrued liabilities related party		12,000		12,000
Accrued interest payable		6,257		3,619
Accrued interest payable related party		222		-
Net cash used in operating activities		(37,556)		(7,397)

CASH FLOWS FROM INVESTING ACTIVITIES:		-		-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings of convertible notes payable		45,000		-
Borrowings from related party debt and short-term advances		11,460		7,843
Net cash provided by financing activities		56,460		7,843

NET CHANGE IN CASH		18,904		446
CASH AT BEGINNING OF PERIOD		413		-
CASH AT END OF PERIOD	$	19,317	$	446

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	-	$	-
Income taxes	$	-	$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accounts payable exchanged for convertible note payable	$	8,270	$	-
Accrued legal fees exchanged for convertible note payable	$	250,000	$	-
Accrued liabilities exchanged for convertible note payable	$	26,000	$	-
Note payable exchanged for convertible note payable	$	17,167	$	-
Accrued interest exchanged for convertible note payable	$	2,663	$	-
Repayment of related party short-term advances with credit card	$	-	$	(660)


The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO ~~QUARTERLY~~THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September~~March 3031, ~~2024~~2025

(Unaudited)

NOTE 1 – ORGANIZATION AND OPERATIONS

~~Organization~~Farmhouse, Inc. (the “Company”) is a Nevada corporation focused on technology and brand development. The Company operates through its wholly owned subsidiaries, including Farmhouse Washington and Farmhouse DTLA, Inc., and holds a portfolio of intellectual property assets, including domains and assorted trademarks. It is currently focused on strategic acquisitions to leverage its public company platform and enhance shareholder value.

~~The~~Share ~~Company~~Exchange ~~was~~Agreement ~~incorporated~~with ~~in June 2013 as Somerset Transition Corporation under the Oklahoma General Corporation Act. In September 2013~~Thrown, the Company was redomesticated in Maryland and changed its name to Somerset Property, Inc. In July 2017, the Company was redomesticated in Nevada and changed its name to Revival, Inc. In June 2019, the Company changed its name to Farmhouse, Inc. to reflect its new business endeavors. LLC

InOn ~~August~~September ~~2019~~10, 2024, the Company ~~acquired~~entered ~~Farmhouse,~~into ~~Inc.,~~ a ~~Washington~~Share ~~corporation~~Exchange Agreement (“~~Farmhouse Washington~~SEA”) aswith ~~its~~Thrown, ~~wholly~~LLC ~~owned subsidiary~~ (~~the~~ “~~Acquisition~~Thrown”) and its members. ~~The~~Thrown ~~financial~~is ~~statements~~a ofbeverage company and its initial product is Good Game by T-Pain, a nootropic esports beverage packaged in 2-ounce servings. Under the SEA, the Company ~~are~~will acquire all the ~~continuation~~membership interests of ~~Farmhouse~~Thrown ~~Washington~~in ~~with~~exchange ~~the~~for ~~adjustment~~5,130,000 tonewly ~~reflect~~issued ~~the~~shares ~~capital~~of ~~structure~~common stock. As of the ~~Company.~~date ~~The~~of ~~consolidated~~this ~~financial~~report, ~~statements~~the ~~also~~transaction ~~include~~has ~~Farmhouse~~not ~~DTLA~~closed, ~~Inc.,~~and adiscussions ~~wholly~~with ~~owned~~Thrown ~~subsidiary~~management ofare ~~Farmhouse~~ongoing. ~~Washington~~See ~~(“DTLA”).~~Note 3.

~~Current~~Proposed ~~Operations~~Acquisition of Ledgewood Holdings, LLC

~~The~~On ~~Company~~June is9, a2025, ~~technology~~the ~~business~~Company ~~with~~entered ~~multiple~~into ~~divisions~~a ~~and~~non-binding aterm ~~portfolio~~sheet ofwith ~~intellectual~~Ledgewood ~~property~~Holdings, ~~including~~LLC ~~the~~(“Ledgewood”), ~~WeedClub®~~a ~~platform,~~multi-unit ~~the~~franchise ~~@420~~operator ~~Twitter~~with ~~handle,~~approximately ~~and~~$31 amillion ~~Web3~~in ~~division~~trailing twelve-month revenue. The ~~Web3~~term ~~division,~~sheet ~~launched~~contemplates inthe ~~December~~acquisition ~~2021,~~of ~~was~~Ledgewood ~~intended~~by tothe ~~facilitate~~Company ~~licensing~~through ~~opportunities~~the ~~between~~issuance ~~established~~of ~~cannabis~~up ~~brands~~to ~~and~~31,000,000 ~~holders~~shares of ~~influential~~the ~~digital~~Company’s ~~collectibles~~common ~~for~~stock. ~~the~~The ~~launch~~term ofsheet ~~branded~~is ~~digital~~non-binding ~~products~~ and ~~accessories.~~subject ~~Revenues~~to ~~from~~the ~~this~~execution ~~initiative~~of ~~have~~definitive ~~been limited~~agreements, and ~~the~~accordingly, ~~Company~~as ~~has~~of ~~ceased~~the ~~pursuing~~date of this ~~line~~report, ofthere ~~business.~~can ~~The~~be ~~Company~~no isassurance ~~now~~that ~~pursuing~~the ~~acquisition~~transaction ~~opportunities~~will tobe ~~leverage~~consummated ~~its~~on ~~public~~the ~~structure~~terms ~~and~~proposed ~~enhance~~or ~~shareholder~~at ~~value~~all.

InGoing ~~line~~Concern ~~with this strategy, on September 10, 2024, the Company entered into a Share Exchange Agreement (“SEA”) with Thrown, LLC (“Thrown”)~~ and ~~its~~Management members. Under the SEA, the Company will acquire all membership interests of Thrown in exchange for 5,130,000 newly issued shares of common stock. This represents approximately 25% of the Company’s total issued and outstanding shares following the closing of the transaction.Plans

AsThe ~~part~~accompanying ofcondensed ~~the~~consolidated ~~SEA,~~financial ~~Thrown’s~~statements ~~management~~have ~~team,~~been ~~including~~prepared ~~key~~assuming ~~executives,~~the Company will continue toas ~~operate~~a ~~the~~going ~~business~~concern. ~~under~~For the ~~Company’s~~three ~~ownership.~~months ~~The~~ended ~~transaction~~March ~~also~~31, ~~includes~~2025, anthe ~~Earnout~~Company ~~Agreement~~incurred ~~that~~a ~~provides~~loss ~~performance-based~~from ~~incentives~~operations of $90,794 aand ~~Voting~~had ~~Agreement~~a ~~that~~stockholders’ ~~outlines~~deficit ~~provisions~~of ~~concerning~~$2,271,137. ~~the~~These ~~voting~~conditions ~~rights~~raise ~~related~~substantial todoubt about the Company’s ~~board~~ability ~~composition~~to ~~and~~continue ~~matters~~as ~~surrounding~~a ~~the~~going ~~SEA,~~concern ~~and~~within anone ~~Investor~~year ~~Rights~~after ~~and~~the ~~Management~~date ~~Agreement~~these ~~that~~financial ~~will~~statements ~~govern~~are ~~future operations and establish ongoing governance structures~~issued.

~~The~~Management ~~transaction~~intends ~~is subject~~ to ~~customary~~address ~~closing~~this ~~conditions,~~uncertainty ~~including~~through ~~the~~continued ~~Company entering into a~~ financing ~~agreement~~from toofficer ~~raise~~loans, ~~between $5 million and $10 million. The transaction is structured to qualify as a tax~~third-~~free~~party ~~exchange under Section 368(a) of the Internal Revenue Code. Completion of the transaction remains subject to various conditions~~borrowings, and ~~there~~equity ~~can~~sales. beWhile no assurance ~~that~~can ~~the~~be ~~SEA will close. As of April 25~~given, ~~2025,~~management ~~the~~believes ~~date~~these ofsources ~~this~~will ~~report,~~provide ~~the~~sufficient ~~SEA~~liquidity ~~has~~to ~~not~~support ~~closed,~~operations ~~and~~in the ~~Company~~near ~~and Thrown remain in discussions~~term. ~~See Note 3 and 14.~~

Going Concern and Management’s Plans

The accompanying unaudited interim condensed consolidated financial statements have been presented on the basis that the Company is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the nine months ended September 30, 2024, the Company had a net loss from operations of $321,456 and as of September 30, 2024, the Company had stockholders’ deficit of $2,247,804. In view of these matters, the recoverability of any asset amounts shown in the accompanying unaudited interim condensed consolidated financial statements is dependent upon the Company’s ability to expand operations and achieve profitability from its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company has financed its activities principally from the sale of its common stock, loans and advances from Company officers, and loans from third parties. The Company intends to finance its future working capital needs from these sources until such time that funds provided by operations are sufficient to fund working capital requirements. Management believes that loans and advances from Company officers, funds raised from the sale of its common stock, and funds raised from loans with third parties allow the Company sufficient capital for operations and to continue as a going concern.

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies is presented to assist the reader in understanding and evaluating the Company’s unaudited interim condensed consolidated financial statements. These accounting policies conform to Generally Accepted Accounting Principles (“GAAP”) in the United States and have been consistently applied in the preparation of these unaudited interim condensed consolidated financial statements.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”), as issued by the Financial Accounting Standards Board (“FASB”), and the rules of the SEC applicable to interim financial reporting. They do not include all of the information and footnotes required for complete annual financial statements and should be read in conjunction with the Company’s 2024 Form 10-K. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. References to the “ASC” refer to the Accounting Standards Codification established by FASB.

Principals of Consolidation

The ~~unaudited interim condensed~~ consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Farmhouse Washington and DTLA ~~(together~~, ~~the “Company”)~~Inc. All ~~material~~ intercompany ~~accounts,~~balances ~~transactions,~~ and ~~earnings~~transactions have been eliminated in consolidation.

Financial Statement Reclassification

Certain amounts in the prior year’s financial statements have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on previously reported net loss or stockholders’ equity.

Cash and Cash Equivalents

Cash and cash equivalents as of September 30, 2024, included cash held in banks. The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

Basis of presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim financial information. They do not include all of the information and footnotes required for complete annual financial statements. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on July 11, 2024. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

Use of Estimates

The preparation of financial statements in ~~conformity~~accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, ~~revenues~~revenue, expenses, and related disclosures. atSignificant ~~the~~estimates ~~date~~include, ofbut ~~the~~are ~~financial~~not ~~statements~~limited ~~and~~to, ~~during~~ the ~~reporting~~valuation ~~periods.~~of ~~Significant~~convertible ~~estimates~~debt ~~include~~and ~~those~~stock-based ~~related to convertible debt~~compensation, deferred tax assets and ~~any~~associated ~~related~~ valuation allowances, ~~contingent assets~~ and ~~liabilities,~~fair ~~and~~value ~~stock-based compensation~~measurements. Actual results could ~~materially~~ differ materially from those estimates. ~~Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.~~

~~Accounts receivable~~Reclassifications

~~Accounts~~Certain ~~receivable~~prior ~~represent~~period amounts ~~due~~have ~~from~~been ~~customers~~reclassified into ~~the~~conform ~~ordinary~~to ~~course of business and are recorded at~~ the ~~invoiced~~current ~~amount.~~period ~~Accounts receivable do not bear interest and are presented net of an allowance for doubtful accounts~~presentation. ~~The~~These ~~Company~~reclassifications ~~evaluates~~had ~~the~~no ~~collectability~~effect ~~of its accounts receivable and establishes an allowance based~~ on apreviously ~~combination~~reported ofnet ~~factors,~~income ~~including~~or ~~historical collection trends and specific information about customer credit risk. When the Company becomes aware of a customer~~stockholders’s ~~inability to meet its financial obligations, a specific allowance for doubtful accounts is recorded~~equity. ~~During the nine months ended September 30, 2024, the Company recognized bad debts of $607 on its accounts receivable.~~

Cash and Cash Equivalents

Cash and cash equivalents consist of cash held in checking and savings accounts and highly liquid investments with original maturities of three months or less at the time of purchase. The Company had no cash equivalents as of March 31, 2025 or December 31, 2024.

Fair Value of Financial Instruments

The Company follows ASC 820, Fair Value Measurements, for assets and liabilities measured at fair value on a recurring or nonrecurring basis. Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between market participants. The three-tier hierarchy prioritizes inputs used in valuation techniques: Level 1 (quoted prices in active markets), Level 2 (observable inputs other than quoted prices), and Level 3 (unobservable inputs). The Company’s financial instruments, including cash, accounts payable, and notes payable, are recorded at cost, which approximates fair value due to their short-term maturities.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers., ~~Revenue~~by isevaluating ~~recognized~~contracts ~~when~~under ~~control of~~ the ~~promised~~five-step ~~goods~~model: or(1) ~~services~~identify isthe ~~transferred~~contract, to(2) ~~customers~~identify inthe anperformance ~~amount~~obligations, ~~that~~(3) ~~reflects~~determine the ~~consideration~~transaction price, (4) allocate the ~~Company~~transaction ~~expects~~price, toand ~~receive~~(5) inrecognize ~~exchange~~revenue ~~for~~as ~~those~~performance ~~goods~~obligations orare ~~services~~satisfied.

~~During~~The ~~the nine months ended September 30, 2024 and 2023, the~~ Company generated ~~revenues~~no ofrevenue ~~$4,154~~for ~~and $10,707, respectively. During~~ the three months ended ~~September~~March 3031, ~~2024~~2025. ~~and~~In ~~2023~~prior periods, the Company generated ~~revenues~~immaterial ofrevenue ~~zero and $5,503, respectively. Revenues were generated~~ from license fees inunder ~~connection with~~ NFT ~~art~~licensing ~~license~~ agreements~~, whereby licensees are granted a limited right to use the Company’s NFTs for the purpose of creating, marketing, and selling branded cannabis and hemp products and accessories~~. The Company’s performance obligation iswas met ~~upon~~when ~~granting~~ the licensee was granted access to the NFTs. ~~Revenue~~As isdiscussed ~~recognized~~in asNote ~~the licensee sells products~~1, ~~based~~the onCompany adoes ~~percentage~~not ofexpect ~~their~~to ~~gross~~generate ~~sales.~~future ~~Fees~~revenue ~~are~~from ~~due~~these ~~the month after~~ agreements.

sales occur. One licensee accounted for 100% of license revenues for each of the nine months ended September 30, 2024 and 2023.

The corresponding costs of revenues associated with license revenues were $1,874 and $5,006 for the nine months ended September 30, 2024 and 2023, respectively, and zero and $2,404 for the three months ended September 30, 2024 and 2023, respectively.

As discussed in Note 1, the Company has ceased pursuing its NFT licensing business and does not expect to generate further licensing revenues. The decision to discontinue this line of business was made as part of a strategic shift to focus on other opportunities, and the Company is no longer actively marketing or entering into new NFT licensing agreements.

Related Party Transactions

The Company ~~identifies~~accounts ~~and~~for ~~discloses transactions with~~ related ~~parties~~party transactions in accordance with ASC 850, Related Party Disclosures. ~~Related~~Transactions ~~party~~with ~~transactions are recorded on terms that are no more favorable to the~~ related parties ~~than~~are ~~those~~identified ~~that~~and ~~would~~evaluated befor ~~available~~appropriate indisclosure ~~similar~~and ~~transactions~~accounting. ~~with~~See ~~unaffiliated~~Note ~~third parties~~6.

~~Earnings~~Commitments ~~(Loss)~~and ~~per Common Share~~Contingencies

~~Net~~The ~~income~~Company ~~(loss)~~evaluates ~~per~~commitments ~~common~~and ~~share~~contingencies ~~is computed~~ in accordance with ASC ~~260~~450, ~~Earnings per Share~~Contingencies. ~~Basic~~Liabilities ~~net~~are ~~income~~accrued ~~(loss)~~when ~~per common share is calculated by dividing net income (loss) by~~ the ~~weighted average number of common shares outstanding during the period. Diluted net income (~~loss) ~~per common share~~ is ~~calculated~~probable byand ~~adjusting~~reasonably ~~the~~estimable. ~~weighted~~Legal ~~average~~costs ~~number~~are ofexpensed ~~common~~as ~~shares outstanding to include potentially dilutive securities~~incurred. AsSee ofNote ~~September 30, 2024 and December 31, 2023, the Company had no potentially dilutive securities~~10.

Segment Reporting

In accordance with ASC 280, Segment Reporting, the Company operates in a single reportable segment. The Chief Financial Officer is the Chief Operating Decision Maker. The CODM reviews financial performance based on consolidated operating results, including revenue, gross profit, and net loss. No disaggregated operating results are regularly reviewed below the consolidated level, and no discrete segment-level information is maintained. To date the Company has generated all revenues from third parties located in the United States and all of the Company’s assets are located in the United States.

Net Income (Loss) per Common Share

Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share include the effect of potentially dilutive securities such as stock options and convertible instruments but are excluded when the effect would be anti-dilutive. As of March 31, 2025 and 2024 the Company had convertible notes outstanding, however, certain events that would trigger, or allow for, conversion had not yet occurred; therefore as of those dates the Company had no potentially dilutive securities.

Stock-Based Compensation

~~Stock~~The Company accounts for stock-based ~~compensation~~awards ~~expense~~in isaccordance with ASC 718, Compensation – Stock Compensation. Equity awards, including restricted stock awards (“RSAs”), are measured at fair value on the grant date ~~based~~and onexpensed over the ~~estimated~~requisite service period. The fair value of RSAs is based on the ~~award~~closing ~~and~~price ~~recognized~~of the Company’s common stock on athe ~~straight-line~~date ~~basis~~of ~~over~~grant. Stock option valuation, when applicable, is based on the ~~vesting~~Black-Scholes ~~period~~option pricing model. See Note 9.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

Subsequent Events

The Company evaluates subsequent events in accordance with ASC 855, Subsequent Events. The Company assesses events occurring after the balance sheet date but before the financial statements are issued to determine whether such events should be recognized in the financial statements or disclosed in the notes. See Note 11.

Recently Issued Accounting Pronouncements

The Company has evaluated all recently issued accounting pronouncements by the Financial Accounting Standards Board ~~(“FASB”)~~, including those not yet effective, and does not expect any of these standards to have a material impact on its unaudited interim condensed consolidated financial statements or related disclosures.

NOTE 3 – DEPOSIT ON INVESTMENT

As discussed in Note 1, the Company entered into a Share Exchange Agreement with Thrown, LLC and its members for a proposed acquisition of all membership interests of Thrown~~. Thrown~~, ~~operating under the brand Nappy Boy Dranks, is~~ a beverage company whose initial product is ~~GamerShot~~Good Game by T-Pain, a nootropic functional esports beverage. ~~packaged~~Pursuant into ~~2-ounce~~the ~~servings~~SEA, the Company issued 187,500 shares to Thrown as an equity deposit at an agreed value of $75,000. The fair market value of the stock on the issuance date, based on the closing price on the OTCQB market, was $0.1396 per share, or approximately $26,175.

~~Pursuant~~Because to the ~~SEA~~closing conditions had not been satisfied as of March 31, 2025, control of Thrown had not transferred under ASC 805. Therefore, the ~~consideration~~Company torecorded bethe ~~provided~~fair tovalue ~~Thrown~~of ~~includes:~~the shares issued as a) anDeposit ~~equity~~for Investment. This deposit ofrepresents ~~$75,000~~an advance made in ~~Company~~anticipation ~~shares~~of completing the acquisition. As of the date of this report, ~~subject~~the totransaction ~~lockup~~had not closed and ~~specific~~discussions ~~return~~with Thrown management regarding closing conditions remain ongoing. If the transaction does not close, b)the ~~cash~~shares ~~compensation~~will ~~contingent~~be ontreated as a break-up fee and charged to expense.

the Company raising $5-$10 million in equity financing, c) equity compensation involving issuance of 5,130,000 shares to Thrown, d) expense reimbursement up to $100,000 for organizational and operating expenses, e) license payment of $50,000 to Nappy Boy Dranks, LLC, and f) additional shares based on sales milestones to be negotiated.

During the three months ended September 30, 2024, the Company and Thrown agreed to a price per share of $0.40 for the Company’s common stock, and the Company issued 187,500 shares to Thrown as the $75,000 equity deposit required under the SEA. The fair market value of the stock on July 6, 2024, measured at the closing price on the OTCQB market, was $0.1396 per share, or approximately $26,175.

Because the closing conditions had not been satisfied as of September 30, 2024, the Company determined that control of the underlying business had not transferred under ASC 805, Business Combinations. As a result, the share issuance did not qualify for recognition as a completed business combination or as an investment. Accordingly, the Company recorded the fair value of the shares issued as a Deposit for Investment as of September 30, 2024. The deposit represents an advance made in anticipation of completing the acquisition. If the acquisition does not close, the shares will be treated as a break-up fee and charged to expense.

As of April 25, 2025, the date of this report, the SEA has not closed, and the Company and Thrown remain in discussions. See Note 14.

NOTE 4 – CONVERTIBLE NOTES PAYABLE, IN DEFAULT

Convertible notes payable is comprised of a promissory note issued to an unrelated individual with a principal amount of $45,000 as of ~~both~~March ~~September 30~~31, ~~2024~~2025 and December 31, ~~2023~~2024. Principal and accrued interest were originally due in July 2018, and the note is currently in default. The note bears interest at a rate of 18% per annum, accrues monthly, and is unsecured.

The note, together with all unpaid accrued interest, is automatically convertible in full upon the closing of a qualified financing. A qualified financing is defined as an equity financing resulting in gross proceeds to the Company of at least $750,000 (including the conversion of this note and other debt). Upon a qualified financing, the conversion price would be equal to 100% of the per share price paid by investors in the financing, subject to the following valuation adjustments: (i) if the Company’s valuation associated with the qualified financing is less than $15,000,000, the conversion price shall be based on a $15,000,000 valuation; and (ii) if the valuation exceeds $30,000,000, the conversion price shall be based on a $30,000,000 valuation.

Interest expense related to the convertible note was $6,082 and $6,059 for the nine months ended September 30, 2024 and 2023, respectively, and $2,042 for each of the three months ended September 30, 2024 and 2023, respectively. Accrued interest was $58,476 and $52,394 as of September 30, 2024 and December 31, 2023, respectively.11

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

Interest expense related to the convertible note was $1,998 and $2,019 for the three months ended March 31, 2025 and 2024, respectively. Accrued interest was $62,515 and $60,517 as of March 31, 2025 and December 31, 2024, respectively.

NOTE 5 – NOTES PAYABLE

InNotes ~~2021,~~payable ~~the~~is ~~Company~~comprised ~~entered into a loan agreement with an unaffiliated individual (the “Lender”) for borrowings up to $75,000 and received a first advance~~ of ~~$50,000. The loan, which was due nine months after~~ the first advance, remains outstanding and in default as of September 30, 2024. The loan bears interest at a rate of 6% per annum. At the Lender’s sole discretion, the maturity date may be extended. Borrowings under this loan are senior in priority to any other indebtedness of the Company. The Company’s Chief Executive Officer personally and unconditionally guaranteed repayment of the loan. following:

Interest expense related to this loan was $2,252 and $2,244 for the nine months ended September 30, 2024 and 2023, respectively, and $756 for each of the three months ended September 30, 2024 and 2023, respectively. Accrued interest was $9,888 and $7,636 as of September 30, 2024 and December 31, 2023, respectively.

	March 31, 2025		December 31, 2024
Loan agreement with an unaffiliated individual, interest at 6% per annum, due December 16, 2021. In default.	$	50,000	$	50,000
Note payable to unaffiliated individual, interest at 20% per annum, due October 26, 2024. In default.		5,000		5,000
Note payable to unaffiliated individual, interest at 20% per annum, due October 26, 2024. In default.		5,000		5,000
Note payable to unaffiliated individual, interest at 12% per annum, due January 2, 2025. (1)		-		11,667
Note payable to unaffiliated individual, interest at 20% per annum, due February 9, 2025. (1)		-		5,500
Note payable to unaffiliated individual, interest at 20% per annum, due March 30, 2025. In default		8,400		8,400
Total Notes Payable	$	68,400	$	85,567

~~During~~(1)Note ~~the~~payable ~~nine~~converted ~~months~~into ~~ended~~a ~~September~~Series ~~30,~~2025 ~~2024,~~Note. ~~the~~See ~~Company~~Note ~~issued the following unsecured promissory notes to unrelated parties:~~7.

Date	Principal Amount	Interest Rate	Maturity Date	Purpose
April 26, 2024	$5,000	20%	October 26, 2024	Cash proceeds
April 26, 2024	$5,000	20%	October 26, 2024	Cash proceeds
July 2, 2024	$11,667	12%	January 2, 2025	Vendor payment
August 9, 2024	$5,500	20%	February 9, 2025	Vendor payment
September 30, 2024	$8,400	20%	March 31, 2025	Vendor payment

In 2021, the Company entered into a loan agreement with an unaffiliated individual (the “Lender”) for borrowings up to $75,000 and received a first advance of $50,000. Borrowings under this loan are senior in priority to any other indebtedness of the Company. The Company’s Chief Executive Officer personally and unconditionally guaranteed repayment of the loan. As of the date of this report, the note remains unpaid and is in default.

~~Each~~Except for the $50,000 note discussed in the paragraph above, each of the notes ~~bears~~to unaffiliated individuals bear interest at the stated annual rate, calculated based on the actual number of days elapsed over a 365-day year. All notes are unsecured and provide for acceleration of payment upon the occurrence of customary events of default, including non-payment, insolvency, bankruptcy, or a change of control of the Company. The notes have not been registered under the Securities Act of 1933, as amended, and the holders have represented that they are acquiring the notes for investment purposes only and not with a view to distribution. ~~As of April 25, 2025, the date of this report, the notes are in default.~~

~~Interest~~On ~~expense~~March ~~related~~31, to2025, ~~these~~two notes ~~was~~in the principal amounts of $111,~~005~~667 and $15,~~367~~500, ~~for~~together ~~the~~with ~~three~~accrued ~~and~~interest ~~nine~~of ~~months~~$1,733 ~~ended~~and ~~September 30~~$705, ~~2024~~respectively, ~~respectively.~~were ~~Accrued~~converted ~~interest~~into ~~was~~new ~~$1,367~~Series as2025 of10% ~~September~~Mandatorily ~~30,~~Convertible ~~2024~~Notes. See Note 7.

~~NOTE~~Interest 6expense ~~– NOTES~~on ~~PAYABLE~~notes ~~– RELATED~~payable ~~PARTY~~was $2,953 and $748 for the three months ended March 31, 2025 and 2024, respectively. Accrued interest was $14,084 and $13,569 as of March 31, 2025 and December 31, 2024, respectively.

~~On August~~ 12, 2024, the Company entered into an unsecured promissory note with the Company’s Chief Executive Officer in the principal amount of $4,500. The note bears interest at a rate of 20% per annum, calculated based on the actual number of days elapsed over a 365-day year. All unpaid principal and accrued but unpaid interest was due and payable in full on February 12, 2025. The note provides for acceleration of payment upon the occurrence of customary events of default, including the Company’s failure to pay amounts due, insolvency, bankruptcy, or a change of control, as defined in the note. Because the note was issued to the Company’s Chief Executive Officer, it is classified as a related party transaction under applicable accounting standards. See Note 12.

~~Interest expense related to this note was $121 for the three months ended September 30~~FARMHOUSE, ~~2024 and accrued interest was $121 as of September 30, 2024~~INC. AsAND ~~of April 25, 2025, the date of this report, the note matured on February 12, 2025, and remains unpaid. Accordingly, the note is in default.~~SUBSIDIARIES

~~NOTE~~NOTES 7TO ~~– DUE~~THE TOCONDENSED ~~RELATED~~CONSOLIDATED ~~PARTIES~~FINANCIAL STATEMENTS

~~Due~~March ~~to related parties totaled $57,978 and $28,958 as of September 30, 2024 and December~~ 31, 2023, respectively. These amounts are comprised of cash advances provided to the Company for operating expenses and direct payments of Company expenses by Company officers. The amounts due to related parties are non-interest bearing and unsecured. See Note 12.2025

For the nine months ended September 30, 2024, Company officers advanced $30,187 to the Company and were repaid $1,167 through the use of the Company’s credit card. For the comparable nine months ended September 30, 2023, Company officers advanced $2,751 to the Company, were repaid $21,255 in cash and $2,490 through the use of the Company’s credit card. (Unaudited)

NOTE 86 – ~~CONVERTIBLE~~DUE ~~NOTES~~TO ~~PAYABLE~~RELATED ~~– LONG-TERM~~PARTIES

InDue ~~May 2023, the Board of Directors authorized an offering of up~~ to ~~$1,000,000~~related ofparties ~~mandatorily~~is ~~convertible~~comprised notes, designated as Series 2023 10% Mandatorily Convertible Notes (the “Series 2023 Notes”), to fund Web3 product development activities as well as sales, marketing, and administrative expenses. During the year ended December 31, 2023, the Company raised $34,000 through the issuance of ~~Series 2023 Notes. The Series 2023 Notes mature 36 months from~~ the ~~issue date (which range between June 1, 2026 and October 2, 2026), and bear interest at 10% per annum.~~following:

The Series 2023 Notes are mandatorily convertible 30 calendar days after the earliest to occur of: (i) the Company’s common stock achieving a closing price greater than $1.00 for ten consecutive trading days (a “Market Forced Conversion”), or (ii) the Company completing an offering of common stock resulting in gross proceeds of at least $1,000,000 (an “Offering Forced Conversion”). Upon conversion, the Series 2023 Notes will automatically convert into shares of common stock at a conversion price equal to 75.8% of: (i) the closing price of the Company’s common stock on the tenth trading day for a Market Forced Conversion, or (ii) the offering price of the Company’s common stock for an Offering Forced Conversion.

	March 31, 2025		December 31, 2024
Loans from Company officers	$	81,009	$	69,549
Accrued liability to contracted CFO		230,000		218,000
Note Payable to Officer, in default		4,500		4,500
Accrued interest on Note Payable to Officer		570		348
Total Due to Related Parties	$	316,079	$	292,397

As of March 31, 2025 and December 31, 2024, loans from Company officers totaled $81,009 and $69,549, respectively. These amounts represent cash advances made by Company officers to fund operating expenses and direct payments made by Company officers on behalf of the Company. All amounts due to related parties are non-interest bearing and unsecured. For the three months ended March 31, 2025, Company officers advanced a total of $11,460 to the Company. For the three months ended March 31, 2024, Company officers advanced $7,843 and were repaid $660 through personal charges to the Company’s credit card.

The Company’s Chief Financial Officer is engaged under a consulting arrangement and is not a W-2 employee. The Company recognized $12,000 in compensation expense for the three months ended March 31, 2025. As of March 31, 2025 and December 31, 2024, accrued but unpaid fees totaled $230,000 and $218,000, respectively, for services provided since 2021.

On August 12, 2024, the Company entered into an unsecured promissory note with the Company’s Chief Executive Officer in the principal amount of $4,500. The note bears interest at a rate of 20% per annum, calculated based on the actual number of days elapsed over a 365-day year. All unpaid principal and accrued but unpaid interest was due and payable in full on February 12, 2025. The note provides for acceleration of payment upon the occurrence of customary events of default, including the Company’s failure to pay amounts due, insolvency, bankruptcy, or a change of control, as defined in the note. Because the note was issued to the Company’s Chief Executive Officer, it is classified as a related party transaction under applicable accounting standards. As of the date of this report, the note remains unpaid and is in default.

Interest expense related to the CEO note was $222 and zero for the three months ended March 31, 2025 and 2024, respectively. Accrued interest was $570 and $348 as of March 31, 2025 and December 31, 2024, respectively.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

NOTE 7 – CONVERTIBLE NOTES PAYABLE – LONG-TERM

Convertible notes payable – long-term is comprised of the following:

	March 31, 2025		December 31, 2024
Series 2023 Notes
Note payable to unaffiliated individual, interest at 10% per annum, $25,000 due June 1, 2026 and $4,000 due September 30, 2026.	$	29,000	$	29,000
Note payable to unaffiliated individual, interest at 10% per annum, due October 2, 2026.		5,000		5,000
Series 2025 Notes				-
Note payable to unaffiliated individual, interest at 10% per annum, due February 24, 2028.		10,000		-
Note payable to unaffiliated individual, interest at 10% per annum, due March 18, 2028. (1)		61,000		-
Note payable to unaffiliated individual, interest at 10% per annum, due March 31, 2028. (2)		6,200		-
Note payable to unaffiliated individual, interest at 10% per annum, due March 31, 2028. (2)		13,400		-
Note payable to unaffiliated individual, interest at 10% per annum, due March 31, 2028. (3)		250,000		-
Note payable to unaffiliated individual, interest at 10% per annum, due March 31, 2028. (4)		8,500		-
Total Convertible Notes Payable – Long-term	$	383,100	$	34,000

See narrative below under The Series 2025 Notes related to these footnotes:

(1)Represents partial conversion of accrued liability.

(2)Represents conversion of existing promissory note.

(3)Represents conversion of accrued legal fees and finance charges.

(4)Represents conversion of existing accounts payable to individual.

The Series 2023 Notes

In May 2023, the Board of Directors authorized an offering of up to $1,000,000 of mandatorily convertible notes, designated as Series 2023 10% Mandatorily Convertible Notes (the “Series 2023 Notes”), to fund Web3 product development activities as well as sales, marketing, and administrative expenses. The Series 2023 Notes are mandatorily convertible 30 calendar days after the earliest to occur of: (i) the Company’s common stock achieving a closing price greater than $1.00 for ten consecutive trading days (a “Market Forced Conversion”), or (ii) the Company completing an offering of common stock resulting in gross proceeds of at least $1,000,000 (an “Offering Forced Conversion”). Upon conversion, the Series 2023 Notes will automatically convert into shares of common stock at a conversion price equal to 75.8% of: (i) the closing price of the Company’s common stock on the tenth trading day for a Market Forced Conversion, or (ii) the offering price of the Company’s common stock for an Offering Forced Conversion.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(Unaudited)

The number of shares issuable upon conversion is determined by adding the principal amount of the Series 2023 Notes, accrued and unpaid interest, and any applicable default interest, and dividing by the applicable conversion price. The conversion price is subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company, combinations, recapitalizations, reclassifications, extraordinary distributions, and similar events. Assuming the Series 2023 Notes are not mandatorily converted as discussed above, maturity will be in the fiscal year ended December 31, 2026.

Interest expense related to the Series 2023 Notes was $~~2,564~~840 and $~~856~~851 for the ~~nine months ended September 30, 2024 and 2023, respectively, and $861 and $651 for the~~ three months ended ~~September~~March 3031, ~~2024~~2025 and ~~2023~~2024, respectively. Accrued interest was $45,~~279~~981 and $15,~~715~~141 as of ~~September~~March 3031, ~~2024~~2025 and December 31, 2023, respectively.

~~NOTE~~The 9Series ~~– STOCKHOLDERS’~~2025 ~~DEFICIT~~Notes

~~Authorized~~For ~~Capital~~the three months ended March 31, 2025, the Company raised an additional $45,000 under the aforementioned offering. These new notes are designated as Series 2025 10% Mandatorily Convertible Notes (the “Series 2025 Notes”). The Series 2025 Notes are identical in all respects to the Series 2023 Notes except they convert at 50% of the offering price, or if the Company’s common stock trades at or above $1.00 per share ($0.50 per share for the March 18 Note) for ten consecutive trading days, in which case they convert at 50% of the closing price on the tenth day. Proceeds from the Series 2025 Notes are being used for general corporate purposes.

~~The~~On ~~Company’s~~February ~~authorized capital consists of 295~~24,~~000,000~~ ~~shares of common stock~~2025, ~~$0.0001~~the ~~par~~Company ~~value~~issued ~~per~~a ~~share,~~Series ~~and~~2025 ~~5,000,000~~Note ~~shares of undesignated preferred stock, $0.0001 par value per share. The Board of Directors may,~~ in ~~its sole discretion, establish par value, divide~~ the ~~shares~~principal ofamount ~~preferred stock into series, and fix and determine the dividend rate, designations, preferences, privileges, and restrictions~~ of ~~any series of preferred stock. As of September 30~~$10,000 ~~2024,~~to ~~and~~an ~~December~~individual ~~31, 2023, the Company had no shares of preferred stock issued or outstanding~~investor.

~~Common~~On ~~stock~~March ~~transactions~~18, 2025, the Company issued a Series 2025 Note in the principal amount of $61,000 to an individual investor. The principal amount includes $26,000 of previously accrued liabilities for services rendered, which was exchanged in accordance with a liability conversion agreement executed on the same date. The remaining $35,000 represents new cash proceeds received by the Company. Upon execution of the Series 2025 Note, the previously recorded liability was extinguished and reclassified as part of the convertible debt obligation.

~~Common~~On ~~stock~~April ~~transactions~~25, ~~for~~2025, the ~~nine~~Board ~~months~~approved ~~ended~~the ~~September~~exchange ~~30,~~of ~~2024~~certain outstanding liabilities into Series 2025 Notes, ~~were~~effective as ~~follows~~of March 31, 2025. These include the following:

·OnA ~~May~~promissory ~~17,~~note ~~2024~~with a principal and accrued interest balance of $6,205, ~~the~~was ~~Board~~exchanged ~~granted~~for ~~Restricted~~a ~~Stock~~new ~~Awards~~Series ~~(“RSAs”)~~2025 ~~totaling~~Note ~~340~~in the face amount of $6,~~000~~200. ~~shares~~The Company recorded a gain on extinguishment of ~~common~~debt ~~stock~~of ~~under~~$5 for the ~~2021~~three ~~Omnibus~~months ~~Incentive~~ended ~~Plan.~~March ~~See~~31, ~~Note~~2025 10upon the exchange.

·OnOutstanding ~~May~~accrued ~~28,~~legal ~~2024,~~fees ~~the~~and ~~Company~~finance ~~issued~~charges 62totaling $424,~~500~~930 ~~shares~~were ofexchanged ~~common~~for ~~stock~~a tonew anSeries ~~unrelated~~2025 ~~third~~Note ~~party~~ in ~~connection~~the ~~with~~face aamount ~~Subscription~~of ~~Agreement~~$250,000. ~~priced~~The atCompany ~~$0.40~~recorded ~~per~~a ~~share,~~gain ~~for~~on ~~cash~~extinguishment ~~proceeds~~of debt of $25174,~~000~~930 for the three months ended March 31, 2025 upon the exchange.

·OnAn ~~September~~outstanding 6,and ~~2024,~~overdue ~~the~~accounts ~~Board~~payable ~~granted~~of an$8,270 ~~RSA~~and accrued interest of ~~10,000~~$230 ~~shares~~was ofexchanged ~~common~~for ~~stock~~a ~~under~~new ~~the~~Series ~~2021~~2025 ~~Omnibus~~Note ~~Incentive~~in ~~Plan.~~the ~~See~~face ~~Note~~amount 10of $8,500.

·OnA ~~July~~promissory 6,note ~~2024,~~with ~~the~~a ~~Company~~principal ~~issued~~balance ~~187,500~~of ~~shares to Thrown~~$11,667 ~~which~~and ~~were~~accrued ~~valued~~interest atbalance of $261,~~175~~733, ~~measured~~was atexchanged ~~the~~for ~~closing~~a ~~price~~new ofSeries ~~the~~2025 ~~Company’s~~Note ~~common~~in ~~stock on~~ the ~~OTCQB~~face ~~market~~amount ~~on the date~~ of ~~issuance~~$13,400. ~~See Note 3.~~

~~As a result of these issuances, the Company had 17,925,950 shares of common stock outstanding as of September 30, 2024.~~15

~~There were no common stock transactions during the nine months ended September 30~~FARMHOUSE, ~~2023~~INC. AND SUBSIDIARIES

~~Shares~~NOTES ~~Reserved~~TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~The~~March Company is required to reserve and keep available from its authorized but unissued shares of common stock a sufficient number to cover shares that could be issued upon conversion of the convertible note payable (see Note 4) and the Series 2023 Notes (see Note 8). The convertible note payable and Series 2023 Notes are not convertible as of September 30, 2024, and will only become convertible upon the occurrence of future events, at which time the conversion prices will be determined. Therefore, the number of shares issuable upon conversion is not currently determinable, and no shares were reserved for future issuance as of September 30, 2024, and December 31, ~~2023.~~2025

~~NOTE 10 – STOCK-BASED COMPENSATION AND RESTRICTED STOCK AWARDS~~(Unaudited)

~~2021~~Interest ~~Omnibus~~expense ~~Incentive~~related ~~Plan~~to the Series 2025 Notes was $234 and zero for the three months ended March 31, 2025 and 2024, respectively. Accrued interest was $234 as of March 31, 2025.

InSubsequent ~~May~~to ~~2021,~~March ~~the Board of Directors approved the Farmhouse~~31, ~~Inc. Omnibus Incentive Plan (the “2021 OIP”). The 2021 OIP permits the granting of nonqualified stock options~~2025, ~~incentive~~there ~~stock~~were ~~options,~~additional ~~stock~~issuances ~~appreciation rights, restricted stock, restricted stock units, performance shares, performance units, other stock-based awards, and cash-based awards. The maximum number~~ of ~~shares~~Series of2025 ~~common stock that may be issued pursuant to awards under the 2021 OIP is 3,000,000~~Notes. ~~Stockholders~~See ~~holding~~Note ~~a majority of the Company’s outstanding common stock ratified the 2021 OIP by written consent~~11.

~~Options~~NOTE ~~granted~~8 under the 2021 OIP may be either “incentive stock options,” as defined in Section 422 of the Internal Revenue Code, or “non-statutory stock options,” subject to Section 83 of the Internal Revenue Code, at the discretion of the Board of Directors and as set forth in the applicable award agreement. The option exercise price may not be less than 100% of the fair market value of the Company– STOCKHOLDERS’s common stock on the date of grant (or 110% in the case of a participant who owns more than 10% of the voting power of all classes of the Company’s stock). Options become exercisable at times and on conditions determined by the Board and must be exercised within ten years from the date of grant (or five years for optionees holding more than 10% of the Company’s voting stock).DEFICIT

~~Restricted~~The ~~stock~~Company ~~awards~~is ~~granted~~authorized ~~under~~to ~~the~~issue ~~2021~~295,000,000 ~~OIP~~shares ~~are~~of ~~issued~~common stock, $0.0001 par value per share, and ~~measured~~5,000,000 atshares ~~fair~~of ~~market~~undesignated preferred stock, $0.0001 par value onper ~~the~~share. ~~date~~The Board of ~~grant~~Directors ~~and~~has ~~typically~~the ~~vest~~authority, in ~~monthly~~its orsole ~~quarterly installments~~discretion, ~~subject~~ to ~~the~~establish ~~recipient’s~~series ~~continued~~of ~~service~~preferred ~~with~~stock ~~the~~and ~~Company~~to onfix the ~~applicable~~par ~~vesting~~value, ~~dates.~~dividend ~~Vesting~~rates, ofdesignations, ~~restricted~~preferences, ~~stock~~privileges, ~~awards~~and isrestrictions ~~based~~of ~~solely~~each ~~on continued service~~series. ~~Stock-based~~No ~~compensation~~shares ~~expense~~of ispreferred ~~recognized~~stock onwere aissued ~~straight-line~~or ~~basis~~outstanding as ~~awards~~of ~~vest~~March 31, ~~with~~2025 aor ~~corresponding~~December ~~credit~~31, ~~to additional paid-in capital~~2024.

~~Restricted~~As ~~Stock~~of ~~Awards~~March 31, 2025, the Company had not reserved any shares of common stock for future issuance. While the Company is required to reserve shares to satisfy potential conversions of its outstanding convertible note payable (~~“RSAs”~~see Note 4) and Series 2023 and Series 2025 Notes (see Note 8), those instruments were not convertible as of March 31, 2025. The number of shares issuable upon conversion is not currently determinable and will depend on future events, including pricing triggers specified in the respective agreements.

AThere ~~summary~~were ofno ~~the~~common ~~Company’s non-vested restricted~~ stock ~~awards~~transactions asduring ~~of September 30, 2024, and changes for~~ the ~~nine~~three months ~~then~~ ended isMarch ~~presented~~31, ~~below:~~2025 and 2024.

Restricted Stock Awards	Shares			Weighted Average Grant Date Fair Value
Non-vested restricted stock awards, Dec. 31, 2023		270,000	$		0.128
Awarded		350,000	$		0.089
Vested		(325,000)	$		0.128
Forfeited		-	$		-
Non-vested restricted stock awards, Sept. 30, 2024		295,000	$		0.081

NOTE 9 – STOCK-BASED COMPENSATION AND RESTRICTED STOCK AWARDS

OnIn May 172021, ~~2024,~~ the Board of Directors ~~granted~~approved athe ~~total~~Farmhouse, ofInc. ~~340,000~~2021 ~~RSAs~~Omnibus ~~under~~Incentive ~~the~~Plan (“2021 OIP”), topermitting ~~advisors~~the ~~deemed~~issuance ~~critical~~of up to ~~closing~~3,000,000 ~~the~~shares ~~SEA~~of ~~with~~common ~~Thrown.~~stock ~~The~~through awards ~~included~~of ~~100~~stock options,~~000~~ ~~RSAs~~stock toappreciation ~~LFSI~~rights, ~~the~~restricted ~~Company’s~~stock, ~~contracted~~restricted ~~CFO~~stock units, ~~and~~performance ~~240~~shares,~~000~~ ~~RSAs~~performance tounits, other stock-based awards, and cash-based awards. The 2021 OIP was ratified by stockholders holding a majority of the Company’s ~~newly~~outstanding ~~engaged legal counsel~~shares.

~~The~~Options ~~RSAs~~granted tounder ~~LFSI~~the ~~vest~~2021 asOIP ~~follows:~~may 50be either incentive stock options,~~000~~ ~~shares~~as ~~vested~~defined onby ~~September~~Section ~~30,~~422 ~~2024,~~of ~~and~~the 25Internal Revenue Code,~~000~~ ~~shares~~or ~~will~~nonqualified ~~vest~~stock onoptions. ~~each~~The exercise price of options must not be less than 100% of the ~~next~~fair ~~two~~market ~~fiscal~~value ~~quarter-ends.~~of ~~The~~the ~~RSAs~~Company’s ~~granted~~common tostock on the ~~legal~~date ~~counsel~~of ~~vest~~grant ~~10,000~~(110% ~~shares~~for ~~monthly~~holders ~~beginning~~of ~~September~~more ~~30,~~than ~~2024,~~10% ~~through~~of ~~May~~the ~~31,~~voting ~~2026~~stock). Options become exercisable as determined by the Board of Directors and expire no later than ten years from the date of grant (five years for optionees owning more than 10% of voting stock).

OnRestricted ~~September~~stock 6,awards ~~2024,~~are ~~the~~issued ~~Board~~at ~~granted~~fair anmarket ~~additional~~value ~~RSA~~on ofthe ~~10,000~~grant ~~shares~~date ~~under~~and ~~the~~typically ~~2021~~vest ~~OIP~~in monthly or quarterly installments, subject to ancontinued ~~advisor~~service. ~~These~~Stock-based ~~shares~~compensation ~~vest~~for inRSAs ~~equal~~is ~~installments~~recognized ofon ~~2,500~~a ~~shares~~straight-line ~~per~~basis ~~month~~over ~~beginning~~the ~~September~~vesting ~~30, 2024~~period.

All RSAs are measured at fair value based on the closing price of the Company’s common stock on the OTCQB market on the grant date. Stock-based compensation expense is recognized as the shares vest. The Company expects to continue issuing restricted stock awards to employees, advisors, and consultants as part of its equity compensation strategy.16

~~No RSAs were granted during the nine months ended September 30~~FARMHOUSE, ~~2023~~INC. AND SUBSIDIARIES

~~Stock-Based~~NOTES ~~Compensation~~TO ~~Expense~~THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~The~~March ~~Company accounts for stock-based compensation in accordance with ASC 718~~31, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the grant-date fair value of awards and is expensed over the requisite service period, which is generally the vesting period. The Company’s stock-based awards consist of RSAs granted under its 2021 OIP. No stock options or other equity awards were granted during the periods presented.2025

For the nine months ended September 30, 2024 and 2023, the Company recognized stock-based compensation expense of $41,685 and $136,452, respectively. For the three months ended September 30, 2024 and 2023, the Company recognized stock-based compensation expense of $5,895 and $19,934, respectively.(Unaudited)

AsRestricted ofStock September 30, 2024, there was $23,974 of unrecognized stock-based compensation expense related to unvested RSAs, which is expected to be recognized over a weighted-average remaining period of approximately 1.43 years, as follows:Awards

Fiscal year ending December 31,
2024 (remaining)	$	7,194
2025		12,580
2026		4,200
Total	$	23,974

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation, recognizing expense based on the grant-date fair value of awards over the requisite service period. All awards were in the form of Restricted Stock Awards granted under the 2021 Omnibus Incentive Plan. RSAs are valued based on the closing price of the Company’s common stock on the OTCQB market on the date of grant, and expense is recognized as the shares vest. No stock options or other equity instruments were granted during the periods presented.

~~NOTE~~The 11following ~~– LITIGATION~~table summarizes RSA activity for the periods presented:

In August 2017, the Company’s subsidiary, DTLA, entered into a Strategic Consulting Agreement (the “SCA”) with Los Angeles Farmers, Inc. (“LAFI”), formerly known as a medical marijuana growing and retail company. In October 2017, DTLA filed litigation in Los Angeles County Superior Court (Case No. BC681251) against LAFI and its principals, seeking to enforce its rights under the SCA. Following a confidential settlement with the principals in January 2020 and a judgment in favor of DTLA against LAFI in April 2021, a court-appointed receiver completed the sale of LAFI in April 2024.

	Number of RSAs		Weighted Average Grant Date Fair Value
Balance as of January 1, 2025		220,000	$	0.076
Awarded		-	$	-
Vested		42,500	$	0.074
Forfeited		-	$	-
Balance as of March 31, 2025		177,500	$	0.077

AsStock-based ofcompensation ~~April~~expense ~~25,~~recognized ~~2025~~was $3,145 for the ~~date~~three ofmonths ~~this~~ended ~~report~~March 31, ~~there~~2025. ~~has~~As ~~been~~of noMarch ~~material~~31, ~~activity~~2025, ~~related~~the toCompany ~~the~~had ~~matter~~$13,635 ~~for~~of ~~more~~unrecognized ~~than~~compensation ~~two~~expense ~~years.~~related ~~The~~to ~~Company~~non-vested ~~does~~RSAs, ~~not~~which ~~expect~~is expected to ~~recover~~be ~~any~~recognized ~~proceeds~~over ~~from~~a ~~the~~weighted-average ~~sale~~remaining ~~and~~period isof noapproximately ~~longer~~1.18 ~~pursuing~~years. ~~any~~Estimated ~~remedies.~~expense ~~Accordingly~~recognition is $9,435 for the ~~matter~~remainder isof ~~considered~~2025 ~~closed~~and $4,200 in 2026.

NOTE 1210 – ~~RELATED~~COMMITMENTS ~~PARTY~~AND ~~TRANSACTIONS~~CONTINGENCIES

AsFrom ~~discussed~~time into ~~Note 6~~time, onthe ~~August~~Company ~~12,~~may ~~2024~~be ~~the~~involved ~~Company~~in ~~entered~~legal ~~into~~proceedings, anclaims, ~~unsecured~~or ~~promissory~~regulatory ~~note~~matters. ~~with~~Management ~~its~~evaluates ~~Chief~~potential ~~Executive~~liabilities ~~Officer~~ in ~~the~~consultation ~~principal~~with ~~amount~~legal ofcounsel ~~$4,500.~~and ~~The~~currently ~~note~~does ~~bears~~not ~~interest~~believe atthat ~~20%~~any ~~per~~existing ~~annum,~~matters ~~matured~~will onhave ~~February~~a ~~12,~~material ~~2025,~~adverse ~~and~~effect ~~remains~~on ~~unpaid~~its asfinancial ofposition ~~April~~or ~~25,~~results ~~2025~~of operations. The ~~note~~Company isalso inhas ~~default~~indemnification ~~and~~agreements iswith ~~classified~~its asofficers aand ~~related~~directors ~~party~~that ~~transaction.~~provide Asfor ofuncapped ~~September 30~~indemnity, ~~2024~~although ~~$4,500~~the inCompany ~~principal~~believes ~~and~~the ~~$121~~likelihood inof ~~accrued~~material ~~interest~~payments ~~was~~is ~~due to the Chief Executive Officer~~remote.

As discussed in Note 7, Officers of the Company have also provided cash advances and paid Company expenses directly to fund operations. Amounts due to related parties totaled $57,978 and $28,958 as of September 30, 2024 and December 31, 2023, respectively. These amounts are unsecured, non-interest bearing, and due on demand.17

~~For the nine months ended September 30~~FARMHOUSE, ~~2024, Company officers advanced $30,187 to the Company and were repaid $1,167 through the use of the Company’s credit card~~INC. ~~For~~AND ~~the comparable nine months ended September 30, 2023, Company officers advanced $2,751 to the Company and were repaid $21,255 in cash and $2,490 through use of the Company’s credit card.~~ SUBSIDIARIES

AsNOTES ofTO ~~September~~THE ~~30,~~CONDENSED ~~2024,~~CONSOLIDATED ~~Company~~FINANCIAL officers owned approximately 41.7% of the Company’s outstanding common stock. The Company has entered into indemnification agreements with its officers and directors covering certain events arising from their service.STATEMENTS

~~NOTE~~March 1331, ~~– COMMITMENTS AND CONTINGENCIES~~2025

~~Contingencies~~(Unaudited)

~~From~~NOTE ~~time~~11 to– SUBSEQUENT time, the Company may become involved in legal proceedings, claims, or regulatory matters arising in the ordinary course of business. The Company assesses its potential liability in connection with these matters by analyzing potential outcomes, assuming various litigation and settlement strategies, and consulting with legal counsel. As of April 25, 2025, the date of this report, there were no material pending legal proceedings against the Company, and management does not believe the outcome of any current claims or legal proceedings will have a material adverse effect on the Company’s financial position, results of operations, or cash flows.EVENTS

~~Indemnification~~As ~~Agreements~~of the date of this report, there were no subsequent events requiring adjustment or disclosure, except as noted below or disclosed elsewhere in these consolidated financial statements.

The ~~Company~~Series ~~has~~2025 entered into indemnification agreements with its officers and directors, under which it has agreed to indemnify them for certain events or occurrences arising from their service in such capacities. The indemnification period extends for the lifetime of the officer or director. The maximum potential future payments under these agreements are unlimited; however, the Company believes the estimated fair value of any potential obligations is minimal. Accordingly, no liability has been recorded as of September 30, 2024, or December 31, 2023.Notes

~~NOTE~~As 14discussed ~~– SUBSEQUENT~~in ~~EVENTS~~Note 7, the Company authorized new Series 2025 Notes under a previous Convertible Promissory Note Offering. The following Series 2025 Notes have been issued under this offering subsequent to March 31, 2025:

As of April 25, 2025, the date of this report, the Company evaluated subsequent events and determined that the following events required disclosure in the accompanying unaudited interim condensed consolidated financial statements for the nine months ended September 30, 2024.

Convertible Note Financing

The Company has authorized a Convertible Promissory Note Offering with the following key terms:

·Interest Rate: 10% per annum

·Maturity: Three years from the date of issuance

·Automatic Conversion:

oIf the Company completes a new equity financing of at least $1,000,000, the note will automatically convert into common stock at a price equal to 50% of the offering price.

oIf the Company’s common stock trades at or above $1.00 per share for ten consecutive trading days, the note will automatically convert at a price equal to 50% of the closing price on the tenth trading day.

·Prepayment: The Company may prepay the notes at any time without penalty; however, each holder will be given five business days’ prior notice to elect conversion before any such prepayment.

·Use of Proceeds: Proceeds from the offering are being used for general corporate purposes.

The following Convertible Notes have been issued under this offering:

·$10,000 issued to an unrelated individual on February 24, 2025.

·$61,000 issued to an unrelated individual on March 18, 2025, consisting of $35,000 in new cash proceeds and $26,000 converted from a previously accrued liability for services rendered.

·$25,000 issued to an unrelated individual on April 16, 2025.

·$25,000 issued to the spouse of a Company director on April 18, 2025. This note was issued on the same terms as those offered to unaffiliated investors and was executed on an arm’s length basis.

·$12,500 issued to an unrelated individual on April 21, 2025.

~~Note~~·$12,500 ~~Conversion~~issued ~~Agreements~~to an unrelated individual on April 28, 2025.

~~On April 25~~·$10,000 ~~2025,~~issued ~~the~~to ~~Board~~an ~~approved~~unrelated ~~the~~individual ~~conversion~~on ofJune ~~certain outstanding liabilities into convertible promissory notes~~23, ~~effective as of March 31,~~ 2025:.

·AProposed ~~promissory~~Acquisition ~~note with a principal and accrued interest balance~~ of $6Ledgewood Holdings,~~200,~~ ~~was converted into a new convertible promissory note under the same terms described above.~~ LLC

~~·Outstanding~~As ~~accrued~~discussed ~~legal~~in ~~fees~~Note ~~and~~1, ~~finance~~on ~~charges~~June ~~totaling~~9, ~~$250~~2025,~~000~~ ~~were~~the ~~converted~~Company entered into a ~~new~~non-binding ~~convertible~~term ~~promissory~~sheet ~~note~~with ~~under~~Ledgewood ~~the~~Holdings, ~~same~~LLC ~~terms~~(“Ledgewood”), ~~described~~a ~~above~~multi-unit franchise operator with approximately $31 million in trailing twelve-month revenue. ~~Upon~~The ~~execution~~term sheet contemplates the acquisition of Ledgewood by the ~~note~~Company through the issuance of up to 31,000,000 ~~any~~shares ~~additional~~of ~~accrued~~the ~~interest~~Company’s orcommon ~~finance~~stock. ~~charges~~The interm ~~excess~~sheet is non-binding and subject to the execution of definitive agreements, and accordingly, as of the ~~$250~~date of this report,~~000~~ ~~balance~~there ~~were~~can ~~waived~~be ~~and~~no ~~discharged~~assurance that the transaction will be consummated on the terms proposed or at all.

~~·An~~Restricted ~~outstanding~~Stock ~~and~~Award ~~overdue accounts payable and finance charges totaling $8,500 were converted into a new convertible promissory note under the same terms described above.~~ Issuances

·AOn ~~promissory~~July ~~note~~16, ~~with~~2025, athe ~~principal~~Board ~~and~~of ~~accrued~~Directors ~~interest~~of ~~balance~~the Company approved the issuance of ~~$13~~a Restricted Stock Award (“RSA”) under the Company’s 2021 Omnibus Incentive Plan to Lang Financial Services, Inc. (“LFSI”), an entity controlled by the Company’s Chief Financial Officer. The RSA consists of 400,000 ~~was~~shares ~~converted~~of ~~into~~the aCompany’s ~~new~~common ~~convertible~~stock ~~promissory~~and ~~note~~was ~~under~~granted in recognition of the ~~same~~CFO’s continued service and increased responsibilities related to audit preparation, SEC filings, and support for proposed merger and acquisition transactions. The shares are subject to the terms ~~described~~and ~~above~~conditions of the Company’s 2021 OIP and the applicable RSA agreement.

~~Update on Share Exchange Agreement with Thrown~~18

As discussed in Notes 1 and 3, the Company entered into a Share Exchange Agreement with Thrown and its members for a proposed acquisition of all membership interests of Thrown. Completion of the transaction remains subject to various conditions and the Company and Thrown remain in discussions. There can be no assurance that the SEA will close.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes included in this Quarterly Report on Form 10-Q, as well as our audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, ~~2023~~2024. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied in these forward-looking statements due to various factors in our Form 10-K and other filings with the Securities and Exchange Commission.

Overview

We are a ~~technology~~Nevada ~~business~~corporation ~~with~~focused ~~multiple~~on ~~divisions~~technology and abrand ~~portfolio~~development. ofWe ~~intellectual~~operate ~~property,~~through ~~including~~our ~~the~~wholly ~~WeedClub®~~owned ~~platform~~subsidiaries, ~~the~~including ~~@420~~Farmhouse ~~Twitter~~Washington ~~handle,~~ and aFarmhouse ~~Web3~~DTLA, ~~division~~Inc. We ~~launched~~hold ~~the~~a ~~Web3~~portfolio ~~division~~of inintellectual ~~December~~property ~~2021~~assets, toincluding ~~facilitate~~domains ~~licensing opportunities between established cannabis brands~~ and ~~holders~~assorted ~~of influential digital collectibles~~trademarks. ~~Revenues~~We ~~from~~are ~~this~~currently ~~initiative~~focused ~~have been limited, and we have ceased pursuing this line of business to focus~~ on ~~other~~ strategic ~~opportunities.~~acquisitions Weto doleverage ~~not~~our ~~currently~~public ~~expect~~company toplatform ~~generate~~and ~~significant~~enhance ~~revenues~~shareholder ~~from existing operations~~value.

~~In line with this strategy, on September 10, 2024, we entered into a~~ Share Exchange Agreement ~~(“SEA”)~~ with Thrown, LLC (“Thrown”) and its members. Thrown is a beverage company operating under the brand Nappy Boy Dranks. Thrown’s initial product is GamerShot, a nootropic esports beverage packaged in 2-ounce servings. Under the SEA, we will acquire all membership interests of Thrown in exchange for 5,130,000 newly issued shares of common stock. This represents approximately 25% of our total issued and outstanding shares following the closing of the transaction. As of April 25, 2025, the transaction has not closed, and discussions with Thrown management are ongoing. Reference is made to Notes 3 and 14 to the interim condensed consolidated financial statements included under Item 1 of this Report for additional information.

On September 10, 2024, we entered into a Share Exchange Agreement (“SEA”) with Thrown, LLC (“Thrown”) and its members. Thrown is a beverage company and its initial product is Good Game by T-Pain, a nootropic esports beverage packaged in 2-ounce servings. Under the SEA, the Company will acquire all the membership interests of Thrown in exchange for 5,130,000 newly issued shares of common stock. As of the date of this report, the transaction has not closed, and discussions with Thrown management are ongoing.

Proposed Acquisition of Ledgewood Holdings, LLC

On June 9, 2025, we entered into a non-binding term sheet with Ledgewood Holdings, LLC (“Ledgewood”), a multi-unit franchise operator with approximately $31 million in trailing twelve-month revenue. The term sheet contemplates the acquisition of Ledgewood through the issuance of up to 31,000,000 shares of our common stock. The term sheet is non-binding and subject to the execution of definitive agreements. As of the date of this report, there can be no assurance that the transaction will be consummated on the terms proposed or at all.

Results of Operations

Three Months Ended ~~September~~March 3031, ~~2024~~2025 Compared to Three Months Ended ~~September~~March 3031, ~~2023~~2024.

Revenue. Revenue for the three months ended ~~September~~March 3031, ~~2024~~2025 was $0zero, compared to $52,~~503~~261 in revenues for the same period in ~~2023.~~2024, ~~The~~which ~~decrease~~were ~~reflects~~generated ~~our~~from ~~decision~~license tofees ~~discontinue~~under ~~the~~ NFT licensing ~~business~~agreements. We do not expect to generate future revenue from these agreements.

~~Operating Expenses. Total operating expenses for the three months ended September 30, 2024, were $92,824, compared to $106,425 for the same period in 2023, as shown below.~~ 19

For the three months ended September 30,	2024	2023
Accounting and Professional	$25,220	$24,708
Wages and benefits	46,036	55,536
Consulting fees	1,275	5,684
Public company related and filing fees.	9,239	6,940
Other general and administrative	11,054	13,557
	$92,824	$106,425

Operating Expenses. Total operating expenses for the three months ended March 31, 2025, were $90,794, compared to $104,103 for the same period in 2024, as shown below.

The decrease was primarily due to lower consulting and stock-based compensation costs, offset by an increase in public company related costs for news releases issued announcing the initial MOU and the SEA with Thrown.

For the three months ended March 31,	2025		2024

Accounting and professional fees	$	23,684	$	29,923
Wages and benefits		46,036		55,536
Consulting fees		625		1,625
Public company related and filing fees		6,164		4,825
Other general and administrative expenses		14,285		12,194
	$	90,794	$	104,103

~~Interest~~The ~~Expense.~~decrease ~~Interest~~in ~~expense~~accounting ~~increased~~and ~~slightly~~professional ~~for~~fees and wages and consulting categories was primarily due to higher stock-based compensation costs recognized in the three months ended ~~September~~March 3031, 2024, as compared to the ~~same~~three ~~period~~months inended ~~2023~~March 31, 2025. The increase in public company and filing fees and other general and administrative expenses was due to ~~interest~~the ~~accrued~~general onincrease ~~new~~in ~~borrowings~~costs and inflation under the normal course of business.

~~Net~~Gain ~~Loss~~on Extinguishment of Debt. ~~Net~~On ~~loss~~March ~~for~~31, ~~the~~2025, ~~three~~accrued ~~months~~legal ~~ended~~fees ~~September~~and ~~30,~~finance ~~2024,~~charges ~~was~~totaling $~~107~~424,~~193,~~930 ~~compared~~were toconverted into a ~~net~~new ~~loss~~Series of2025 ~~$116,358~~Note ~~for~~in the ~~same~~face ~~period~~amount inof ~~2023~~$250,000. ~~The~~We ~~improvement~~recorded ~~was~~a ~~primarily~~gain ~~due~~on toextinguishment ~~reduced~~of ~~operating~~debt ~~expenses~~of ~~mentioned~~$174,930 ~~above~~upon the conversion.

~~Nine~~Interest ~~Months~~Expense. ~~Ended~~Interest ~~September~~expense 30increased slightly for the three months ended March 31, ~~2024~~2025, ~~Compared~~compared to ~~Nine~~the ~~Months~~same ~~Ended~~period ~~September~~in 302024, ~~2023~~due to new borrowings.

~~Revenue~~Net Income/Loss. ~~Revenue~~Net income for the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, was $468,~~154~~288, compared to a net loss of $10116,~~707~~071 for the same period in ~~2023~~2024. The ~~decrease~~gain ~~reflects~~on ~~our~~extinguishment ~~decision~~of debt of $174,935 attributed to ~~discontinue~~the net income for the ~~NFT~~three ~~licensing~~months ~~business~~ended March 31, 2025. Additionally, there was reduced stock-based compensation costs during the three months ended March 31, 2025, as mentioned above.

Operating Expenses. Total operating expenses for the nine months ended September 30, 2024, were $323,736, compared to $408,447 for the same period in 2023, as shown below:

For the nine months ended September 30,	2024	2023
Accounting and Professional	$104,262	$157,383
Wages and benefits	157,108	166,608
Consulting fees	3,525	31,302
Public company related and filing fees.	23,302	19,778
Other general and administrative	35,539	33,376
	$323,736	$408,447

The decrease was primarily due to lower consulting and stock-based compensation costs, as well as reduced professional fees for accounting and audit services, offset by an increase in public company related costs for news releases issued announcing the initial MOU and the SEA with Thrown.

Interest Expense. Interest expense increased slightly for the nine months ended September 30, 2024, compared to the same period in 2023, due to interest accrued on new borrowings.

Net Loss. Net loss for the nine months ended September 30, 2024, was $362,383, compared to a net loss of $440,750 for the same period in 2023. The improvement was primarily due to reduced operating expenses.

Liquidity and Capital Resources

Cash Flow and Working Capital

We had ~~zero~~$19,317 ~~cash~~ and ~~cash~~$413 ~~equivalents~~in cash as of ~~both~~March ~~September 30~~31, ~~2024,~~2025 and December 31, ~~2023~~2024, respectively. Our working capital deficit was $2 1,~~239~~914,~~979~~212 as of ~~September~~March 3031, ~~2024~~2025, compared to $12,~~944~~334,~~281~~745 as of December 31, ~~2023~~2024. We continue to experience limited access to capital and expect that additional financing will be necessary to fund our operations. Market conditions for microcap companies remain challenging, making it difficult to secure favorable terms. Our history of operating losses and our working capital deficit raise substantial doubt about our ability to continue as a going concern. Although we are actively seeking to obtain additional capital, there can be no assurance that such financing will be available on acceptable terms, or at all.

Cash Flow from Financing Activities

We have historically funded our operations primarily through related party advances, private placements, and the issuance of debt. ~~During~~For the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, we ~~completed~~raised ~~the~~an ~~following~~additional ~~funding transactions: proceeds from the sale of common stock of~~ $2545,000; ~~borrowings~~with on notes payable from unrelated parties of $35,567; borrowings from our Chief Executive Officer of $4,500; and borrowings of related party debt and short-term advances of $30,187. Reference is made to Notes 5 and 6 to the ~~interim~~following ~~condensed~~funding ~~consolidated~~transactions: ~~financial statements included under Item 1 of this Report for additional information.~~

·On February 24, 2025, we issued a Series 2025 Note in the principal amount of $10,000 to an individual investor.

·On March 18, 2025, we issued a Series 2025 Note in the principal amount of $61,000 to an individual investor. The principal amount includes $26,000 of previously accrued liabilities for services rendered, which was exchanged in accordance with a liability conversion agreement executed on the same date. The remaining $35,000 represents new cash proceeds.

Reference is made to Notes 7 to the interim condensed consolidated financial statements included under Item 1 of this Report for additional information.

We expect to require additional financing to support our ongoing operations and strategic growth initiatives. These conditions raise substantial doubt about our ability to continue as a going concern, which is dependent upon obtaining sufficient capital to fund operations and achieve profitability. Management is evaluating various financing alternatives, including potential equity or debt offerings and strategic partnerships. If we are unable to obtain additional financing, we may be required to further curtail or cease operations.

Subsequent Event Financing

Subsequent to ~~September~~March 3031, ~~2024~~2025, we raised an additional ~~capital~~$85,000 ~~through~~with ~~a Convertible Note Offering (~~the ~~“Offering”),~~following asfunding ~~follows:~~ transactions

·$10,000 issued to an unrelated individual on February 24, 2025.

·$61,000 issued to an unrelated individual on March 18, 2025, consisting of $35,000 in new cash proceeds and $26,000 converted from a previously accrued liability for services rendered.

·$25,000 issued to an unrelated individual on April 16, 2025.

·$25,000 issued to the spouse of a Company director on April 18, 2025. This note was issued on the same terms as those offered to unaffiliated investors and was executed on an arm’s length basis.

the same terms as those offered to unaffiliated investors and was executed on an arm’s length basis.

·$12,500 issued to an unrelated individual on April 21, 2025.

The notes issued under the Offering bear interest at a rate of 10% per annum and mature three years from their respective dates of issuance. The notes are automatically convertible into shares of our common stock upon the occurrence of certain events, including: (i) the completion of a new equity offering of at least ·$112,~~000,000,~~500 orissued ~~(ii)~~to ~~the~~an ~~Company’s~~unrelated ~~common~~individual stock trading at or above $1.00 per share for ten consecutive trading days. The conversion price will equal 50% of the price per share of the new equity offering or 50% of the tenth day’s closing price, depending on ~~the~~April ~~trigger event. We may prepay the notes at any time without penalty~~28, ~~subject to the holders’ right to convert during a five-day notice period~~2025. ~~Proceeds from the Offering are being used for general corporate purposes, including working capital and operational expenses.~~

~~Reference~~·$10,000 isissued ~~made~~ to ~~Note~~an 14unrelated toindividual ~~the~~on ~~interim~~June ~~condensed~~23, ~~consolidated financial statements included under Item 1 of this Report for additional information~~2025. ~~These financings are not expected to materially change our financial condition.~~

Proceeds are being used for general corporate purposes, including working capital and operational expenses. Reference is made to Note 11 to the interim condensed consolidated financial statements included under Item 1 of this Report for additional information. These financings are not expected to materially change our financial condition.

Significant Estimates and Assumptions

The preparation of our consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. These estimates are based on historical experience, current conditions, and other reasonable factors. Actual results could differ materially from these estimates. We review these estimates and assumptions regularly and update them as new information becomes available.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision of our Principal Executive Officer and Principal Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures as of ~~September~~March 3031, ~~2024~~2025, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our officers concluded that our disclosure controls and procedures were not effective as of that date.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the ~~quarter~~three months ended ~~September~~March 3031, ~~2024~~2025, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness

Our controls and procedures are designed to provide reasonable, not absolute, assurance of achieving their objectives. Because of inherent limitations, no control system can prevent all errors or fraud.

PART II – OTHER INFORMATION

None.

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may become involved in legal proceedings, claims, or regulatory matters arising in the ordinary course of business. We assess our potential liability in connection with these matters by analyzing potential outcomes, assuming various litigation and settlement strategies, and consulting with legal counsel. As of ~~April 25, 2025,~~ the date of this report, there were no material pending legal proceedings against us, and we ~~does~~do not believe the outcome of any current claims or legal proceedings will have a material adverse effect on our financial position, results of operations, or cash flows.

In August 2017, our subsidiary, DTLA, entered into a Strategic Consulting Agreement (the “SCA”) with Los Angeles Farmers, Inc. (“LAFI”), formerly known as a medical marijuana growing and retail company. In October 2017, DTLA filed litigation in Los Angeles County Superior Court (Case No. BC681251) against LAFI and its principals, seeking to enforce our rights under the SCA. Following a confidential settlement with the principals in January 2020 and a judgment in favor of DTLA against LAFI in April 2021, a court-appointed receiver completed the sale of LAFI in April 2024.

As of April 25, 2025, the date of this report, there has been no material activity related to the matter for more than two years. We do not expect to recover any proceeds from the sale and are no longer pursuing any remedies. Accordingly, the matter is considered closed.

ITEM 1A. RISK FACTORS

We qualify as a smaller reporting company, as defined by Item 10 of Regulation S-K and, thus, are not required to provide the information required by this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

~~During the nine months ended September 30, 2024, we issued:~~None

~~·340,000 shares of common stock on May 17, 2024, pursuant to Restricted Stock Awards granted under the 2021 Omnibus Incentive Plan;~~ 22

·62,500 shares of common stock on May 28, 2024, to an unrelated third party under a Subscription Agreement at $0.40 per share, for cash proceeds of $25,000;

·10,000 shares of common stock on September 6, 2024, pursuant to a Restricted Stock Award under the 2021 Omnibus Incentive Plan; and

·187,500 shares to Thrown on July 6, 2024, pursuant to the SEA with Thrown.

Reference is made to Note 9 to the interim condensed consolidated financial statements included under Item 1 of this Report for additional information.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

As of ~~April~~March 2531, 2025, ~~the date of this report,~~ we were in default under the following promissory notes:

·a $45,000 convertible note issued to an unrelated individual, which matured in July 2018~~, and remains unpaid~~.

·a $50,000 loan ~~agreement entered into~~ with an unrelated individual in 2021; ~~the~~which ~~maturity~~matured ~~date may be extended at the lender’s discretion, but the loan remains~~ in ~~default~~December 2021.

·a $45,~~500~~000 ~~related party~~ note issued to ~~our~~an ~~Chief~~unrelated ~~Executive~~individual ~~Officer,~~which matured in ~~February~~October ~~2025, and remains unpaid~~2024.

·a $5,000 note issued to an unrelated individual, which matured in October 2024~~, and remains unpaid~~.

·a $54,~~000~~500 related party note issued to anour ~~unrelated~~Chief ~~individual,~~Executive Officer which matured inon ~~October~~February ~~2024~~12, ~~and remains unpaid~~2025.

·a $118,~~667~~400 note issued to anGSB ~~unrelated individual~~Holdings, LLC which matured inon ~~January~~March ~~2025~~30, ~~and remains unpaid~~2025.

·$5,500 note issued to an unrelated individual, matured in February 2025, and remains unpaid.

·$8,400 note issued to an unrelated individual, matured in March 2025, and remains unpaid.

These defaults may impact our ability to obtain future financing and could result in potential legal action by noteholders. Reference is made to Notes 4, 5, and 6 to the interim condensed consolidated financial statements included under Item 1 of this Report for additional information.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.OTHER INFORMATION

None.

ITEM 6.EXHIBITS

The exhibits required to be filed herewith by Item 601 of Regulation S-K, as described in the following index of exhibits, are attached hereto unless otherwise indicated as being incorporated by reference, as follows:

Exhibit Number		Description

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act. *

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act. *

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, City of San Francisco, State of California, on ~~April~~July 2522, 2025.

By:	/s/ Evan Horowitz
	EVAN HOROWITZ
	Chief Executive Officer, Director

Pursuant to the requirements of the Securities Act of 1933, this registrant statement has been signed by the following persons in the capacities and on the dates indicated.

By:	/s/ Evan Horowitz
	EVAN HOROWITZ
	Chief Executive Officer, Director

By:	/s/ Lanny R. Lang
	LANNY R. LANG
	Chief Financial Officer, Chief Accounting Officer
	(Principal Financial and Accounting Officer)

By:	/s/ Michael Landau
	MICHAEL LANDAU
	Chief Technology Officer, Treasurer, Director

By:	/s/ Leslie Katz
	LESLIE KATZ
	Director

Filing Compare · FARMHOUSE, INC. /NV